These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 2870677)
1. The status of vaccines to meningococcal and gonococcal disease. Gotschlich EC Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):341-55. PubMed ID: 2870677 [TBL] [Abstract][Full Text] [Related]
2. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. Noronha CP; Struchiner CJ; Halloran ME Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439 [TBL] [Abstract][Full Text] [Related]
3. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development. Jennings HJ Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499 [No Abstract] [Full Text] [Related]
4. Development of a meningococcal vaccine. Poolman JT Infect Agents Dis; 1995 Mar; 4(1):13-28. PubMed ID: 7728353 [No Abstract] [Full Text] [Related]
5. New concepts in vaccines for mucosal non-enteric human bacterial pathogens. Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958 [No Abstract] [Full Text] [Related]
6. Neisseria proteomics for antigen discovery and vaccine development. Christodoulides M Expert Rev Proteomics; 2014 Oct; 11(5):573-91. PubMed ID: 25017717 [TBL] [Abstract][Full Text] [Related]
20. Development of a gonorrhoea vaccine: prospects, strategies and tactics. Gotschlich EC Bull World Health Organ; 1984; 62(5):671-80. PubMed ID: 6150769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]